Filters
Type 2 diabetes (T2D) patients receiving a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and a sodium-glucose cotransporter-2 inhibitor (SGLT-2i) concomitantly appear to be at lower risk of dementia compared with those receiving a GLP-1 RA or SGLT-2i monotherapy, according to a study.
Intracranial abscesses in paediatric patients, although rare, need intensive multidisciplinary care, suggests a study, noting significant heterogeneity in current treatment strategies.
Researchers from the Chinese University of Hong Kong (CUHK) have developed a novel molecule, BB56, which can potentially serve as a lead compound for the development of new drugs for neuroinflammatory disorders.
A study from Singapore shows the potential of a virtual reality (VR)-based cognitive–motor dual-task training (CDTT) programme to improve gait performance in functionally independent older adults with mild cognitive impairment (MCI).
A hearing aid intervention does little to reduce the incidence of dementia-level impairment in older adults with coexisting hearing loss and mild cognitive impairment (MCI), as shown in the CHOICE trial.
New drug applications approved by US FDA as of 16-30 September 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Individuals with hypertensive disorders of pregnancy (HDP) may be at increased risk of dementia, as suggested in a retrospective cohort study.
Fourteen years after the last evidence-based recommendations from the American Academy of Neurology and the American Headache Society (AAN/AHS) on migraine prevention, new guidance now reflects a significantly broader treatment landscape. It incorporates established therapies alongside newer migraine-specific approaches, including oral calcitonin gene-related peptide (CGRP) receptor antagonists such as atogepant, and extends its scope to both episodic and chronic migraine*. [Neurology 2026;107(7):e214881]
Use of statins is associated with a lower incidence of remote seizures following a first status epilepticus event, according to a retrospective study.
Congenital toxoplasmosis, syphilis, rubella, cytomegalovirus, or herpes simplex (TORCH) infections are rare but are associated with intellectual disability and autism, as shown in a study.